share_log
Breakings ·  Aug 9 19:01
Precision BioSciences Inc - TG Therapeutics Anticipates Commencing a Phase 1 Clinical Trial in 2024.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment